Cargando…
OXCT1 regulates NF-κB signaling pathway through β-hydroxybutyrate-mediated ketone body homeostasis in lung cancer
Autores principales: | Lu, Zhuo, Han, Tianyu, Wang, Tao, Gan, Mingxi, Xie, Caifeng, Yu, Bentong, Wang, Jian-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201587/ https://www.ncbi.nlm.nih.gov/pubmed/37223533 http://dx.doi.org/10.1016/j.gendis.2022.04.020 |
Ejemplares similares
-
Frataxin controls ketone body metabolism through regulation of OXCT1
por: Dong, Yi NA, et al.
Publicado: (2022) -
Ketone body β-hydroxybutyrate is an autophagy-dependent vasodilator
por: McCarthy, Cameron G., et al.
Publicado: (2021) -
On the nutritional and therapeutic effects of ketone body d-β-hydroxybutyrate
por: Yao, Aliya, et al.
Publicado: (2021) -
Ketone body β-hydroxybutyrate (BHB) preserves mitochondrial bioenergetics
por: Llorente-Folch, I., et al.
Publicado: (2023) -
OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Ding, Jinsheng, et al.
Publicado: (2021)